METISOL-125 Injection

Product Overview

METISOL-125 Injection is a corticosteroid injection containing Methylprednisolone Sodium Succinate equivalent to Methylprednisolone 125 mg. It is supplied as a sterile injectable formulation intended for IM/IV use.

Methylprednisolone is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties. METISOL-125 is formulated for situations where corticosteroid therapy is required and an injectable route is clinically appropriate.

METISOL-125 Injection contains Methylprednisolone Sodium Succinate equivalent to Methylprednisolone 125 mg. Methylprednisolone belongs to the corticosteroid class of medicines and is used for its anti-inflammatory and immunosuppressive effects.

The injectable formulation provides a parenteral option when corticosteroid therapy is required and the healthcare professional considers the IM or IV route appropriate.

METISOL-125 is presented as a 10 mL injection and contains 125 mg equivalent of Methylprednisolone as specified on the product presentation.

Availability & Franchise Enquiries

For the latest METISOL-125 Injection price, stock availability, pack presentation, minimum order quantity, distribution opportunities, PCD pharma franchise availability and commercial terms, contact Positive Medicare directly.

Product availability, pricing and business terms may vary and should be confirmed with the Positive Medicare team before placing an order.

IMPORTANT : METISOL-125 Injection should be used only under the direction and supervision of a qualified healthcare professional. The information provided on this page is intended for product and pharmaceutical business information purposes and should not be considered a substitute for professional medical advice, diagnosis or treatment.